Novo Nordisk A/S Common Stock (NVO)
Stock-Based Compensation
kr 0.00
TTM · Period ending: · DKK
NVO Stock-Based Compensation
Latest reportedkr 0.00 DKKperiod ending
Latest reportedkr 0.00 DKKperiod ending
NVO TTM Stock-Based Comp · DKK (kr 0.00 → kr 0.00)
TTM stock-based compensation
High-resolution chart · PNG
NVO stock-based compensation history
Trailing twelve months (TTM) · DKK. Each value covers four complete reported quarters.
| Period ending | Stock-Based Compensation (DKK) |
|---|---|
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 1,539,000,000 | |
| 1,539,000,000 | |
| 1,539,000,000 | |
| 1,539,000,000 | |
| 1,040,000,000 | |
| 1,040,000,000 | |
| 1,040,000,000 | |
| 1,040,000,000 | |
| 823,000,000 | |
| 823,000,000 | |
| 823,000,000 | |
| 823,000,000 | |
| 363,000,000 | |
| 363,000,000 | |
| 363,000,000 | |
| 363,000,000 | |
| 414,000,000 | |
| 414,000,000 | |
| 414,000,000 | |
| 414,000,000 | |
| 292,000,000 | |
| 292,000,000 | |
| 292,000,000 | |
| 292,000,000 | |
| 368,000,000 | |
| 368,000,000 | |
| 368,000,000 | |
| 368,000,000 | |
| 442,000,000 | |
| 442,000,000 | |
| 442,000,000 | |
| 442,000,000 | |
| 371,000,000 | |
| 371,000,000 | |
| 371,000,000 | |
| 371,000,000 | |
| 409,000,000 | |
| 409,000,000 | |
| 409,000,000 | |
| 409,000,000 | |
| 308,000,000 | |
| 308,000,000 | |
| 308,000,000 | |
| 308,000,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |